Role of leukocyte immunoglobuin G receptors in vaccine-induced immunity to Streptococcus pneumoniae.

Members of the leukocyte immunoglobulin (Ig) G receptor (FcgammaR) family play a key role in antibody-mediated phagocytosis and can either enhance antigen presentation or down-modulate immune responses. We studied immune responses to a pneumococcal conjugate (pneumococcal polysaccharide serotype 1 [PPS1]-tetanus toxoid) and antibody-mediated protection in mice deficient for individual FcgammaRs and complement receptor 3 (CR3). FcR gamma chain-deficient (FcR gamma chain(-/-)) mice, which lack expression of both FcgammaRI and III, had significantly lower anti-PPS1 IgG2b and IgG3 responses than did wild-type mice, whereas FcgammaRII-deficient (FcgammaRII(-/-)) mice had significantly higher IgG2a and IgG3 titers. Wild-type and FcgammaRII(-/-) mice were protected against infection with pneumococcal serotype 1, whereas immunized FcR gamma chain(-/-) and FcgammaRIII-deficient mice were not. Immunized CR3-deficient mice were protected against disease, and complement depletion had little effect on protection. These data indicate that activatory leukocyte FcgammaR, but not FcgammaRII (a murine homologue of human FcgammaRIIb), contributes to IgG-mediated protection against pneumococcal disease.

[1]  J. Ravetch,et al.  Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells , 2002, The Journal of experimental medicine.

[2]  P. Appelbaum.  Resistance among Streptococcus pneumoniae: Implications for drug selection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  N. Greenspan,et al.  γ3 Gene-Disrupted Mice Selectively Deficient in the Dominant IgG Subclass Made to Bacterial Polysaccharides. II. Increased Susceptibility to Fatal Pneumococcal Sepsis Due to Absence of Anti-Polysaccharide IgG3 Is Corrected by Induction of Anti-Polysaccharide IgG11 , 2002, The Journal of Immunology.

[4]  G. van Ommen,et al.  FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. , 2002, Immunity.

[5]  N. Greenspan,et al.  IgG Subclass Made to Bacterial Polysaccharides. II. Increased Susceptibility to Fatal Pneumococcal Sepsis Due to Absence of Anti-Polysaccharide IgG3 Is Corrected by Induction of Anti-Polysaccharide IgG1 , 2002 .

[6]  J. V. D. van de Winkel,et al.  Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. , 2001, Journal of immunological methods.

[7]  J. Younger,et al.  Systemic and lung physiological changes in rats after intravascular activation of complement. , 2001, Journal of applied physiology.

[8]  I. Jónsdóttir,et al.  Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IGg subclasses after intranasal immunization. , 2001, The Journal of infectious diseases.

[9]  I. Jónsdóttir,et al.  Are the Opsonophagocytic Activities of Antibodies in Infant Sera Measured by Different Pneumococcal Phagocytosis Assays Comparable? , 2001, Clinical Diagnostic Laboratory Immunology.

[10]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[11]  I. Jónsdóttir,et al.  Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. , 2001, The Journal of infectious diseases.

[12]  J. V. Ravetch,et al.  IgG Fc receptors. , 2001, Annual review of immunology.

[13]  I. Jónsdóttir,et al.  Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies. , 2000, Microbial pathogenesis.

[14]  J. Ravetch,et al.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. , 2000, Immunity.

[15]  Takashi Saito,et al.  Immune Complex and Fc Receptor-Mediated Augmentation of Antigen Presentation for in Vivo Th Cell Responses1 , 2000, The Journal of Immunology.

[16]  M. Ono,et al.  Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. , 2000, The Journal of experimental medicine.

[17]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[18]  S. Romero-Steiner,et al.  Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. , 2000, The Journal of infectious diseases.

[19]  D. Musher,et al.  Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia , 2000 .

[20]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. , 2000, The Pediatric infectious disease journal.

[21]  T. Honjo,et al.  High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia , 1999, The Journal of experimental medicine.

[22]  I. Jónsdóttir,et al.  Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines with Nontoxic Mutants of Escherichia coliHeat-Labile Enterotoxins as Adjuvants Protects Mice against Invasive Pneumococcal Infections , 1999, Infection and Immunity.

[23]  I. Jónsdóttir,et al.  Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines Protects Mice against Invasive Pneumococcal Infections , 1999, Infection and Immunity.

[24]  J. V. D. van de Winkel,et al.  Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. , 1999, The Journal of infectious diseases.

[25]  P. Ricciardi-Castagnoli,et al.  Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization , 1999, The Journal of experimental medicine.

[26]  T. K. van den Berg,et al.  Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). , 1998, Journal of immunology.

[27]  T. Yamazaki,et al.  Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. , 1998, The Journal of clinical investigation.

[28]  G. Vidarsson,et al.  Fc receptor and complement receptor-mediated phagocytosis in host defence. , 1998, Current opinion in infectious diseases.

[29]  S. Amigorena,et al.  Type II and III Receptors for Immunoglobulin G (IgG) Control the Presentation of Different T Cell Epitopes from Single IgG-complexed Antigens , 1998, The Journal of experimental medicine.

[30]  R. Graziano,et al.  Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies , 1997 .

[31]  S Askari,et al.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. , 1996, Immunity.

[32]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB , 1996, Nature.

[33]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .

[34]  T. Saito,et al.  FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo. , 1996, Blood.

[35]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[36]  J. Henrichsen,et al.  Six newly recognized types of Streptococcus pneumoniae , 1995, Journal of clinical microbiology.

[37]  P. Capel,et al.  Fcã Receptor Iia (Cd32) Heterogeneity In Patients With Recurrent Bacterial Respiratory Tract Infections , 1994 .

[38]  J. Ravetch.  Fc receptors: Rubor redux , 1994, Cell.

[39]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[40]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[41]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[42]  M. Leinonen,et al.  Antibody response to pneumococcal capsular polysaccharide vaccine in African children. , 1991, The Pediatric infectious disease journal.

[43]  K. Klugman.  Pneumococcal resistance to antibiotics , 1990, Clinical Microbiology Reviews.

[44]  M. Arnaout,et al.  Structure and function of the leukocyte adhesion molecules CD11/CD18. , 1990, Blood.

[45]  T. Springer,et al.  Mechanisms for regulating expression of membrane isoforms of Fc gamma RIII (CD16). , 1989, Science.

[46]  J. Kinet,et al.  A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit , 1989, Nature.

[47]  M. Hostetter,et al.  Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. , 1986, The Journal of infectious diseases.

[48]  C. Janeway,et al.  Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. , 1986, Journal of immunology.

[49]  P Karma,et al.  Prevention of otitis media in children by pneumococcal vaccination. , 1985, American journal of otolaryngology.

[50]  K. Warren,et al.  Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing. , 1983, Journal of immunology.

[51]  H. van Dijk,et al.  Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. , 1983, Journal of immunological methods.

[52]  M. Neuberger,et al.  Activation of mouse complement by monoclonal mouse antibodies , 1981, European journal of immunology.

[53]  I. Mellman,et al.  Purificaton of a functional mouse Fc receptor through the use of a monoclonal antibody , 1980, The Journal of experimental medicine.